Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women. 1989

P Vague, and I Juhan-Vague, and V Chabert, and M C Alessi, and C Atlan
Service de Médecine Interne et Nutrition, University of Marseilles Medical School, France.

Epidemiologic data strongly suggest that upper distribution of body fat and high plasminogen activator inhibitor (PAI) activity are risk factors for cardiovascular disease. Therefore, a link between these two parameters was evaluated by studying 51 menstrually active nondiabetic obese women. In this group positive correlations were observed between body mass index (BMI), waist to hip circumference ratio (W/H ratio, which estimates body fat distribution), plasma insulin, and PAI activity. In addition, plasma triglycerides were related to the W/H ratio and insulin and PAI activity. Partial correlations revealed that BMI was independently and solely related to W/H ratio, which was also independently related to plasma insulin, which in turn related to PAI activity. These results suggest that upper body fat distribution acts as a risk factor of cardiovascular disease through its association with high PAI activity.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

P Vague, and I Juhan-Vague, and V Chabert, and M C Alessi, and C Atlan
January 1993, Romanian journal of internal medicine = Revue roumaine de medecine interne,
P Vague, and I Juhan-Vague, and V Chabert, and M C Alessi, and C Atlan
January 2018, International journal of endocrinology,
P Vague, and I Juhan-Vague, and V Chabert, and M C Alessi, and C Atlan
March 1993, Arteriosclerosis and thrombosis : a journal of vascular biology,
P Vague, and I Juhan-Vague, and V Chabert, and M C Alessi, and C Atlan
September 1996, Molecular medicine (Cambridge, Mass.),
P Vague, and I Juhan-Vague, and V Chabert, and M C Alessi, and C Atlan
January 2014, Annals of gerontology and geriatric research,
P Vague, and I Juhan-Vague, and V Chabert, and M C Alessi, and C Atlan
July 2000, Metabolism: clinical and experimental,
P Vague, and I Juhan-Vague, and V Chabert, and M C Alessi, and C Atlan
June 1999, Arteriosclerosis, thrombosis, and vascular biology,
P Vague, and I Juhan-Vague, and V Chabert, and M C Alessi, and C Atlan
October 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
P Vague, and I Juhan-Vague, and V Chabert, and M C Alessi, and C Atlan
June 1988, Thrombosis and haemostasis,
P Vague, and I Juhan-Vague, and V Chabert, and M C Alessi, and C Atlan
September 1991, International journal of obesity,
Copied contents to your clipboard!